Jeffrey Greenfield, MD, PhD
Dr. Greenfield’s directs multiple research projects pertaining to pediatric brain tumors, in particular, basic research examining the brain tumor microenvironment, tumor immunology, and precision medicine. This research has been externally funded and widely published and he has received national awa
The Weill Cornell Medicine Pediatric Brain and Spine Center, located on the Upper East Side campus of New York-Presbyterian/Weill Cornell Medical Center, is nationally recognized for its leadership in the treatment of disorders of the central nervous system in children, particularly brain and spinal cord tumors. It is also the home of the Weill Cornell Medicine Children’s Brain Tumor Project, a research initiative aimed solely at finding new treatment options for rare and often inoperable tumors that strike children and adolescents.
The Clinical Neuro-Oncology Program at the Weill Cornell Brain and Spine Center offers world-class research and medical treatment for cancers affecting the brain and spine. Their experts treat all types of malignant adult and pediatric brain tumors, including primary and metastatic tumors. The program sees hundreds of patients each year with both newly-diagnosed and/or recurrent tumors.
The program offers a wide spectrum of brain tumor clinical trials which make the most recent and promising investigational regimens available to patients who participate in these trials.
The research initiative at the Children’s Brain Tumor Project focuses on exploring pediatric brain tumors from multiple vantage points that integrates key neuroscientific disciplines. This approach enables the lab team to gain a true understanding of these diseases and how to approach treatment more effectively.
The initiative consists of four united research efforts under the same roof - developmental biology, immunotherapy, precision medicine and drug delivery - studying rare pediatric brain tumors from different strategic angles that inform one another in an effort to accelerate cures.
Esteban Uceda | Clinical Research Coordinatorhttps://weillcornellbrainandspine.org/pediatric
David Pisapia, MD
Dr. Pisapia's research interests include furthering the molecular characterization of brain tumors in an effort to reveal therapeutically and prognostically meaningful subclassifications of heterogeneous brain tumors that are often lumped into a single diagnostic entity.
Christopher E. Mason, PhD
Current Research Interest: New biochemical and computational methods in functional genomics; novel techniques in next-generation sequencing; algorithms for tumor evolution, genome evolution, DNA and RNA modifications; algorithms for genome/epigenome engineering; international standards for clinical-
Olivier Elemento, PhD
Big Data analytics with experimentation to develop entirely new ways to help prevent, diagnose, understand, treat and ultimately cure cancerSystems biology of regulatory networks in normal and malignant cellsCancer genomics and precision medicineEpigenomics of cancerTumor genome evolution, anticance
Nadia Dahmane, PhD
Dr. Dahmane’s current research focuses a group of proteins called transcription factors that regulate how different genes are expressed during both brain development and brain cancer progression. Her laboratory has identified a critical novel transcription factor protein (called RP58) that is indisp
I am a recent graduate from Amherst College, where I majored in neuroscience, and started working with the CBTN in 2019. As a research technician and tissue coordinator at Weill Cornell Medicine, I take care of the banking of tissue samples and the generation of cell lines from this tissue for our p